Ergo Bio Opportunity Investments II, LP

Opportunity fundmanaged by Dcvc· Delaware
Vintage
2024
Form D sold
$121,000
Early deploymentClosed to new capitalADV: Venture Capital Fund
More
As of · the latest observation of this vehicle; each figure below carries its own filing date

Nothing material in the last 365 days. Last change: 2 Feb 2024, Latest Form D filed on 2 Feb 2024: $121K sold of $121K offered, 10 investors. A Form D amount is what was sold at the filing, never a final close.

Drawing the relationship network…

Amounts, each with its basis

Vintage
2024basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$121,000what may be sold, not what was raised; file 021-504255, sworn by the adviser or filed under this vehicle
Form D sold
$121,000as of the filing of Feb 2, 2024, 10 investors
First sale
Jan 4, 2024
Reported GAV
unknown
Owners (ADV)
unknown
Reported on ADV
unknown

Fundraising evidence

Closed to new capital
Form D filed or amended 2024-02-02: the stated $121,000 offering reported fully sold (fr-1)
evidence dated Feb 2, 2024.

Lifecycle

Early deployment
vintage within 2 years
age years: 2first sale: Jan 4, 2024vintage year: 2024adv gav as of: n/avintage basis: Form d first saleform d sold: $121,000form d offering: $121,000form d latest filed at: Feb 2, 2024

The fund's own reporting through time

0 Form ADV filings
No Form ADV reporting row: this vehicle is known from Form D only.

Principals and agents

2 principals on Form D, 0 placement agents
  • Vandon Duong Executive Officer
  • Ergo Bio Opportunity Management, LLC Director

Service providers

none named
No auditor, administrator, custodian or placement agent is named for this vehicle on a filing DFX holds.

Limited partners and their reported performance

0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.

Known LPs and allocators

0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.

Investments attributed to this vehicle

0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.

Timeline

1 event
  1. Feb 2, 2024
    Ergo Bio Opportunity Investments II, LP filed Form D: $121,000 sold of $121,000, Venture Capital Fund
    Form D filed Fact Form D

Evidence

16 observations
Every observation on this vehicle
  • Entity type: Limited Partnership Feb 2, 2024 Fact Form D
  • Form D fund type: Venture Capital Fund Feb 2, 2024 Fact Form D
  • Form D industry group: Pooled Investment Fund Feb 2, 2024 Fact Form D
  • Amendment: false Feb 2, 2024 Fact Form D
  • Revenue range (Form D): Decline to Disclose Feb 2, 2024 Fact Form D
  • Incorporated: withinFiveYears Feb 2, 2024 Fact Form D
  • Jurisdiction: Delaware Feb 2, 2024 Fact Form D
  • Amount sold (Form D): $121,000 Feb 2, 2024 Fact Form D
  • Offering amount (Form D): $121,000 Feb 2, 2024 Fact Form D
  • Exemptions: 06b, 3C, 3C.1 Feb 2, 2024 Fact Form D
  • First sale: 2024-01-04 Feb 2, 2024 Fact Form D
  • Investors (Form D): 10 Feb 2, 2024 Fact Form D
  • Minimum investment (Form D): 0 Feb 2, 2024 Fact Form D
  • Securities offered: pooled Feb 2, 2024 Fact Form D
  • Office address: Feb 2, 2024 Fact Form D
  • Year of incorporation: 2024 Feb 2, 2024 Fact Form D

Record history

1 dated event on the change ledger, latest event first
  • Form D filed
    2024-02-02source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.